Thus, it is possible to speculate that the administration of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors could increase the risk of CVD as well as VTE in RA as observed in the general population.[32–35]. The gene discussed is PTGS2; the disease is rheumatoid arthritis.